Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3

Author:

DUMOUTIER Laure1,LEJEUNE Diane1,HOR Simon2,FICKENSCHER Helmut3,RENAULD Jean-Christophe1

Affiliation:

1. The Ludwig Institute for Cancer Research, Brussels Branch, and the Experimental Medicine Unit, Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, avenue Hippocrate 74, B-1200-Brussels, Belgium

2. Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, U.K.,

3. Virology Department, Hygiene Institute, Ruprecht-Karls University, Heidelberg, Germany

Abstract

In the present paper, we report the identification of a new gene encoding a transmembrane protein of 520 amino acids, showing 22% amino acid identity with the extracellular domain of the interleukin (IL)-20 receptor. This gene, termed likely interleukin or cytokine receptor-2 (LICR2), is located on chromosome 1, at 25kb from the IL22R (IL-22 receptor) gene, and is constitutively expressed in most tissues. A chimaeric receptor, consisting of the extracellular domain of the IL-10 receptorα chain and the intracellular domain of LICR2, activated signal transducer and activator of transcription (STAT)1, STAT2, STAT3 and STAT5 upon IL-10 stimulation, in a Janus kinase 1-dependent manner. In contrast, none of the IL-10-related cytokines described so far could activate LICR2-transfected cells, suggesting that LICR2 is a signalling receptor for a new cytokine of the IL-10 family.

Publisher

Portland Press Ltd.

Subject

Cell Biology,Molecular Biology,Biochemistry

Cited by 116 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The role and application of three IFN-related reactions in psoriasis;Biomedicine & Pharmacotherapy;2023-11

2. Cytokines and microRNAs in SARS-CoV-2: What do we know?;Molecular Therapy - Nucleic Acids;2022-09

3. The gamble between oncolytic virus therapy and IFN;Frontiers in Immunology;2022-08-25

4. Prospective roles of IL-24 in the tumorigenesis and development of cancers;Acta Poloniae Pharmaceutica - Drug Research;2022-01-18

5. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases;Frontiers in Immunology;2021-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3